King’s College London – UK
Up to one billion people, nearly 1 in 6 of the world’s population, suffer from neurological disorders.
The Maurice Wohl Clinical Neuroscience Institute at King’s College London is one of Europe’s largest centres for interdisciplinary neuroscience excellence. It is also a key research facility in the UK’s efforts to fast-track new treatments to patients affected by neurological disorders, such as stroke, dementia, Parkinson’s disease, schizophrenia, epilepsy, multiple sclerosis and motor neurone disease.
The 6,500 sq metre, state-of-the-art institute which opened in 2015, brings together a network of patients and carers, with world-renowned clinicians and scientists from multi-disciplines including: neuroimaging, neurology, psychiatry, genetics, molecular cellular biology and drug discovery. Together they are driving forward a shared mission to advance our understanding of disease mechanisms, to improve accuracy of diagnosis and develop new therapies and methods of care for these devastating and, as yet, incurable disorders.
